These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 30075248)

  • 1. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum to "Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model" [International Journal of Pharmaceutics 549 (2018) 218-229].
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2019 Mar; 558():441. PubMed ID: 30765106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo.
    Salmasi Z; Hashemi M; Mahdipour E; Nourani H; Abnous K; Ramezani M
    Biotechnol Prog; 2020 Nov; 36(6):e3025. PubMed ID: 32410328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
    Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
    J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
    Grisendi G; Bussolari R; Cafarelli L; Petak I; Rasini V; Veronesi E; De Santis G; Spano C; Tagliazzucchi M; Barti-Juhasz H; Scarabelli L; Bambi F; Frassoldati A; Rossi G; Casali C; Morandi U; Horwitz EM; Paolucci P; Conte P; Dominici M
    Cancer Res; 2010 May; 70(9):3718-29. PubMed ID: 20388793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma.
    Chen K; Cao X; Li M; Su Y; Li H; Xie M; Zhang Z; Gao H; Xu X; Han Y; Zhou J; Wang W
    Theranostics; 2019; 9(10):2984-2998. PubMed ID: 31244937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.
    Yuan Z; Kolluri KK; Sage EK; Gowers KH; Janes SM
    Cytotherapy; 2015 Jul; 17(7):885-96. PubMed ID: 25888191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site.
    Rivoltini L; Chiodoni C; Squarcina P; Tortoreto M; Villa A; Vergani B; Bürdek M; Botti L; Arioli I; Cova A; Mauri G; Vergani E; Bianchi B; Della Mina P; Cantone L; Bollati V; Zaffaroni N; Gianni AM; Colombo MP; Huber V
    Clin Cancer Res; 2016 Jul; 22(14):3499-512. PubMed ID: 26944067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-loaded TRAIL-exosomes derived from induced neural stem cells for brain cancer therapy.
    Zhang X; Taylor H; Valdivia A; Dasari R; Buckley A; Bonacquisti E; Nguyen J; Kanchi K; Corcoran DL; Herring LE; Steindler DA; Baldwin A; Hingtgen S; Satterlee AB
    J Control Release; 2024 Aug; 372():433-445. PubMed ID: 38908756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
    Morishita M; Takahashi Y; Matsumoto A; Nishikawa M; Takakura Y
    Biomaterials; 2016 Dec; 111():55-65. PubMed ID: 27723556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
    Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
    [No Abstract]   [Full Text] [Related]  

  • 15. Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy.
    Jiang L; Gu Y; Du Y; Tang X; Wu X; Liu J
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42411-42428. PubMed ID: 34464081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway.
    Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X
    Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered human mesenchymal stem cells for neuroblastoma therapeutics.
    Nieddu V; Piredda R; Bexell D; Barton J; Anderson J; Sebire N; Kolluri K; Janes SM; Karteris E; Sala A
    Oncol Rep; 2019 Jul; 42(1):35-42. PubMed ID: 31115546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
    Choi SA; Hwang SK; Wang KC; Cho BK; Phi JH; Lee JY; Jung HW; Lee DH; Kim SK
    Neuro Oncol; 2011 Jan; 13(1):61-9. PubMed ID: 21062796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.
    Fecker LF; Rückert S; Kurbanov BM; Schmude M; Stockfleth E; Fechner H; Eberle J
    Hum Gene Ther; 2011 Apr; 22(4):405-17. PubMed ID: 20977303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL-overexpressing Adipose Tissue-derived Mesenchymal Stem Cells Efficiently Inhibit Tumor Growth in an H460 Xenograft Model.
    Un Choi Y; Yoon Y; Jung PY; Hwang S; Hong JE; Kim WS; Sohn JH; Rhee KJ; Bae KS; Eom YW
    Cancer Genomics Proteomics; 2021; 18(4):569-578. PubMed ID: 34183389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.